Segall Bryant & Hamill, LLC Eli Lilly & CO Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

A detailed history of Segall Bryant & Hamill, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 11,417 shares of LLY stock, worth $9.08 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

11,417

Holding current value

$9.08 Million

% of portfolio

0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $8.82 Million - $11 Million	11,417 New	11,417 $10.1 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $20,430 - $28,167	-47 Reduced 0.38%	12,472 $6.7 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $177,123 - $236,834	-505 Reduced 3.88%	12,519 $5.87 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $59,951 - $70,410	193 Added 1.5%	13,024 $4.47 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $27,653 - $32,221	-86 Reduced 0.67%	12,831 $4.69 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $59,888 - $68,249	-202 Reduced 1.54%	12,917 $4.18 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $18,396 - $21,599	-66 Reduced 0.5%	13,119 $4.25 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $144,569 - $179,662	-616 Reduced 4.46%	13,185 $3.78 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $56,212 - $69,760	-250 Reduced 1.78%	13,801 $3.81 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $145,148 - $178,625	655 Added 4.89%	14,051 $3.25 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $45,137 - $58,385	250 Added 1.9%	13,396 $3.07 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $51,925 - $67,219	-316 Reduced 2.35%	13,146 $2.46 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $42,399 - $56,104	325 Added 2.47%	13,462 $2.27 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $292,440 - $338,260	2,000 Added 17.96%	13,137 $1.94 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $109,545 - $131,836	-803 Reduced 6.73%	11,137 $1.83 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $47,620 - $58,940	-400 Reduced 3.24%	11,940 $1.66 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $7,377 - $9,137	-69 Reduced 0.56%	12,340 $1.62 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $100,818 - $117,681	-910 Reduced 6.83%	12,409 $0
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $56,768 - $66,820	510 Added 3.98%	13,319 $0
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $19,591 - $21,948	-185 Reduced 1.42%	12,809 $1.48 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $2,747 - $3,433	-32 Reduced 0.25%	12,994 $0
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $198,182 - $227,451	2,618 Added 25.15%	13,026 $0
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $43,674 - $46,845	533 Added 5.4%	10,408 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $761,066 - $844,707	9,875	9,875 $0

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Eli Lilly & CO Transaction History